Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Sorafenib for Inoperable Stage III Non-Small Cell Lung Cancer
Clinical trial NCT00417248 · TERMINATED
Trial details
- NCT number
- NCT00417248
- Sponsor
- Nasser Hanna, M.D.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-06-01
- Primary completion
- 2008-04-01
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.